← Back to Clinical Trials
Recruiting NCT06029348

Cerebrovascular Health and Resilience in Midlife

Trial Parameters

Condition Psychological Stress
Sponsor University of Pittsburgh
Study Type INTERVENTIONAL
Phase N/A
Enrollment 450
Sex ALL
Min Age 40 Years
Max Age 59 Years
Start Date 2023-10-17
Completion 2029-06-30
Interventions
Paced Auditory Serial Addition Task

Brief Summary

This study examines cardiovascular responses to a brief psychological challenge under laboratory conditions among adult volunteers. The study volunteers are asked to complete two study sessions. In one session, the volunteers are asked to provide demographic and health-related information via questionnaires and an interview. In that session, volunteers would then be asked to undergo evaluations of their body composition, blood pressure, heart rate, and other signs of cardiovascular function and health. Lastly, volunteers would be asked to take part in a brief and challenging psychological task after a period of rest while cardiovascular activity is measured. In the other session, volunteers are asked to undergo magnetic resonance imaging and to complete neuropsychological tests of memory, attention, and processing speed. In addition to these two sessions, volunteers are asked to complete online questionnaires. The study is designed to examine associations between transient changes in cardiovascular activity induced by the psychological task, measures of overall cardiovascular health, and measures of cerebrovascular health measured by magnetic resonance imaging. Study results are expected to provide new information about the relationships between cardiovascular activity changes to psychological challenges and cardiovascular and cerebrovascular health in adults.

Eligibility Criteria

Inclusion Criteria: * Able to attend 2 study visits at the University of Pittsburgh campus in Oakland (Pennsylvania) * Able to read and speak English Exclusion Criteria: * Uncontrolled hypertension (systolic blood pressure \>160 or diastolic blood pressure \>100 mmHg) * Current use of anticonvulsant, anti-Parkinson, neuroleptic, or antipsychotic medications * Current use of glucocorticoids (e.g., oral prednisone) or ephedrine * Current chronic conditions of the lungs, liver and kidney, as well as cancer (chemotherapy and radiation) treatment in the past 12 months (allowances are made for non-melanoma skin cancer treatment, controlled asthma, and allergy inhalers) * Self-reported major neurological disorders or brain injuries (e.g., multiple sclerosis, cerebral palsy, major head injury) * Self-reported psychotic illnesses (mania, bipolar disorder, schizophrenia) * Current pregnancy or childbirth within the past 6 months * Suspected mild cognitive impairment or dementia * Self reported s

Related Trials